Preeclampsia, Fetal Growth Restriction, and 24-Month Neurodevelopment in Very Preterm Infants.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Original Publication: Chicago, IL : American Medical Association, [2018]-

Pre-Eclampsia*/epidemiology ; Fetal Growth Retardation*/epidemiology; Humans ; Female ; Pregnancy ; Male ; Infant, Newborn ; Prospective Studies ; Adult ; Child Development/physiology ; Child, Preschool ; Infant, Extremely Premature ; Developmental Disabilities/epidemiology ; Developmental Disabilities/etiology ; Infant ; Infant, Premature ; Neurodevelopmental Disorders/epidemiology ; Neurodevelopmental Disorders/etiology ; Cohort Studies

Importance: Preeclampsia has direct influences on a developing fetus and may impact postnatal health, and fetal growth restriction (FGR) is often seen co-occurring with preeclampsia. The development of children born very preterm after preeclampsia diagnosis with and without FGR is not well characterized.
Objective: To examine the associations of preeclampsia and FGR with developmental and/or behavioral outcomes in a cohort of very preterm infants.
Design, Setting, and Participants: In this cohort study, infants in the prospective Neonatal Neurobehavior and Outcomes in Very Preterm Infants study were enrolled between April 2014 and June 2016 from 9 US university-affiliated neonatal intensive care units (NICUs). Eligible infants were born before 30 weeks' gestation. Infants were excluded for any major congenital anomalies and for maternal age younger than 18 years or cognitive impairment impacting the ability to provide informed consent. Data analysis was performed from November 2023 to January 2024.
Exposure: Maternal preeclampsia and FGR in very preterm infants.
Main Outcomes and Measures: The Bayley-III cognition, motor, and language scores less than 85 (-1 SD) indicated developmental delay. Child Behavior Checklist/Preschool 1.5-5 T-scores greater than or equal to 64 for internalizing, externalizing, or total problems indicated clinical importance.
Results: Of 704 infants enrolled, 529 (mean [SD] gestational age, 27.0 [1.9] weeks; 287 male [54.3%]) were studied at 24-month follow-up. A total of 94 infants' mothers had preeclampsia (23.2%), and 46 infants (8.7%) had FGR. In adjusted models, preeclampsia was not associated with Bayley-III (cognitive, B = 3.43 [95% CI, -0.19 to 6.66]; language, B = 3.92 [95% CI, 0.44 to 7.39]; motor, B = 1.86 [95% CI, -1.74 to 5.47]) or Child Behavior Checklist/Preschool 1.5-5 (internalizing, B = -0.08 [95% CI, -2.58 to 2.73]; externalizing, B = 0.69 [95% CI, -1.76 to 3.15]; total, B = 0.21 [95% CI, -2.48 to 2.91]) outcomes. FGR was associated with significantly lower Bayley-III scores (cognitive, B = -8.61 [95% CI, -13.33 to -3.89]; language, B = -8.29 [95% CI, -12.95 to -3.63]; motor, B = -7.60 [95% CI, -12.40 to -2.66]), regardless of preeclampsia status.
Conclusions and Relevance: In this cohort study of preterm infants, preeclampsia was not associated with developmental and/or behavioral outcomes, but infants with FGR may be prone to developmental delays. These findings suggest future areas of research for understanding the roles of preeclampsia and FGR separately and together in early child development for preterm infants.

JAMA Netw Open. 2022 Jul 1;5(7):e2222249. (PMID: 35849396)
Arch Dis Child. 2020 May;105(5):421-427. (PMID: 31666245)
BMC Pediatr. 2003 Dec 16;3:13. (PMID: 14678563)
J Obstet Gynaecol Res. 2022 Apr;48(4):912-919. (PMID: 35240725)
Early Hum Dev. 2020 Mar;142:104954. (PMID: 32007912)
J Matern Fetal Neonatal Med. 2016;29(14):2268-74. (PMID: 26364996)
JAMA Psychiatry. 2020 Aug 1;77(8):823-829. (PMID: 32236510)
Child Neuropsychol. 2016;22(2):247-54. (PMID: 25319507)
Pediatrics. 2004 Mar;113(3 Pt 2):641-67. (PMID: 14993524)
Obstet Gynecol. 2000 Dec;96(6):950-5. (PMID: 11084184)
Pediatrics. 2009 Jan;123(1):313-8. (PMID: 19117897)
Early Hum Dev. 2019 Mar;130:96-100. (PMID: 30711915)
Am J Perinatol. 2022 Jul;39(9):921-929. (PMID: 34753185)
Front Med (Lausanne). 2022 Aug 30;9:984291. (PMID: 36111112)
Semin Fetal Neonatal Med. 2018 Apr;23(2):119-125. (PMID: 29221766)
Dev Cogn Neurosci. 2020 Oct;45:100811. (PMID: 32823180)
Eur J Pediatr. 2022 Sep;181(9):3401-3411. (PMID: 35802207)
JAMA Pediatr. 2020 Aug 1;174(8):772-781. (PMID: 32453414)
J Autism Dev Disord. 2008 Sep;38(8):1542-54. (PMID: 18324467)
Mol Neurobiol. 2016 Mar;53(2):1009-1019. (PMID: 25575681)
Paediatr Perinat Epidemiol. 2012 Mar;26(2):101-8. (PMID: 22324495)
Pediatr Res. 2023 Aug;94(2):762-770. (PMID: 36841884)
Pediatr Res. 2018 Apr;83(4):767-777. (PMID: 29072866)
Eur J Obstet Gynecol Reprod Biol. 2003 Sep 22;110 Suppl 1:S93-7. (PMID: 12965096)
JAMA Netw Open. 2022 Apr 1;5(4):e226561. (PMID: 35394511)
Compr Physiol. 2020 Dec 9;11(1):1315-1349. (PMID: 33295016)
PLoS One. 2018 May 31;13(5):e0198083. (PMID: 29851971)
BJOG. 2014 Nov;121(12):1482-91. (PMID: 24703162)
Fetal Diagn Ther. 2014;36(2):86-98. (PMID: 24457811)
J Perinatol. 2009 Oct;29(10):680-4. (PMID: 19609308)
PLoS One. 2018 Nov 21;13(11):e0207884. (PMID: 30462738)
Pediatrics. 2014 Jan;133(1):e14-22. (PMID: 24298003)
Arch Gynecol Obstet. 2016 Oct;294(4):673-9. (PMID: 27522600)
Semin Perinatol. 2014 Apr;38(3):177-82. (PMID: 24836830)
JAMA Psychiatry. 2018 Aug 1;75(8):809-819. (PMID: 29874359)
Acta Paediatr. 2010 Oct;99(10):1504-9. (PMID: 20456275)
Early Hum Dev. 2016 Nov;102:47-50. (PMID: 27659865)
Psychiatry Res. 2019 Feb;272:392-397. (PMID: 30605798)
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):1-7. (PMID: 23746796)
AJNR Am J Neuroradiol. 2017 Apr;38(4):801-806. (PMID: 28126749)
J Pediatr. 2013 Nov;163(5):1289-95. (PMID: 23968750)
Pediatr Res. 2020 Mar;87(4):721-729. (PMID: 31600769)
Pediatr Clin North Am. 2019 Apr;66(2):403-423. (PMID: 30819345)
Pregnancy Hypertens. 2014 Jul;4(3):209-14. (PMID: 26104607)
J Autism Dev Disord. 2010 May;40(5):548-54. (PMID: 19936906)
Lancet. 2021 Jul 24;398(10297):341-354. (PMID: 34051884)
JAMA Pediatr. 2015 Feb;169(2):154-62. (PMID: 25485869)
Pediatrics. 2004 Mar;113(3 Pt 2):676-8. (PMID: 14993526)
Semin Perinatol. 2014 Apr;38(3):167-76. (PMID: 24836829)
Early Hum Dev. 1999 May;55(1):39-50. (PMID: 10367981)
Pregnancy Hypertens. 2018 Apr;12:23-28. (PMID: 29674194)
Early Hum Dev. 2004 Jan;76(1):39-46. (PMID: 14729161)
Early Hum Dev. 2014 Feb;90(2):99-101. (PMID: 24388669)
Trends Neurosci. 2020 Apr;43(4):253-268. (PMID: 32209456)
Am J Perinatol. 2016 Jul;33(8):738-44. (PMID: 26890439)
Semin Perinatol. 2004 Feb;28(1):67-80. (PMID: 15058904)
Lancet. 2010 Aug 21;376(9741):631-44. (PMID: 20598363)
Arch Dis Child Fetal Neonatal Ed. 2015 Jul;100(4):F301-8. (PMID: 25834170)
Indian Pediatr. 2019 Jun 15;56(6):485-488. (PMID: 31278229)
Br J Psychiatry. 2018 Mar;212(3):142-147. (PMID: 29436313)

Date Created: 20240705 Date Completed: 20240705 Latest Revision: 20240708

20240708

PMC11227083

10.1001/jamanetworkopen.2024.20382

38967923